Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

FibroGen Inc

FibroGen Inc

FGEN · NASDAQ
FGEN · NASDAQ

Next Earnings: 11 Aug 2025

7.25
USD-0.39-5.10%

Latest News

    SeekingAlpha

    FibroGen sells China unit to AstraZeneca for $160 million

      @Reuters
      Reuters

      FibroGen's neuromuscular disorder therapy fails late-stage study https://t.co/7ddwv1skhH https://t.co/plEQOCUb3z

        @DeItaone
        DeItaone

        Upgrades $FGEN $FLT $INTR $LYB $NFE https://t.co/eAzzXmW2uv https://t.co/jLlWRKEGap

          @Reuters
          Reuters

          U.S. FDA declines to approve FibroGen's anemia drug https://t.co/G1Iw0P9LnF https://t.co/c2jD018nKU

            @eWhispers
            eWhispers

            #earnings after the close https://t.co/lObOE0dgsr $AMC $APPS $PRPL $DDD $CHGG $SDC $ELY $INO $NTR $HALO $REAL $LOTZ $CF $PLNT $SAIL $HBM $PRTK $ETH $ADMS $NLS $CBT $AEMD $ACM $GOSS $WES $RPAY $API $MESA $WTRH $STE $APPF $BARK $DOOR $FGEN $ADAP $ORGO $ATCO $ARCT $CMP $NGL $LU https://t.co/AePy0Mp5xb

            Hold

            Strong Buy

            Buy

            Hold

            Sell

            Strong Sell

            Day Range

            7.22USD
            7.69USD

            52 Week Range

            0.18USD
            7.71USD

            Market Cap

            25.02MUSD

            lock-imagelock-image

            Get Full Access with Profit PRO

            See which Billionaires own this investment

            About

            General Information

            Type

            Common Stock

            Exchange

            NASDAQ

            Currency Code

            USD

            Currency Name

            US Dollar

            Country Name

            USA

            Country ISO

            US

            ISIN

            US31572Q8087

            CUSIP

            31572Q808

            Sector

            Healthcare

            Industry

            Biotechnology

            Fiscal Year End

            December

            IPO date

            -

            Updated At

            -

            Highlights

            PE Ratio

            -

            PEG Ratio

            -

            Book Value

            -53.66

            Dividend Share

            -

            Dividend Yield

            -

            Earnings Share

            -30

            Wall Street Target Price

            250.00

            EPS Estimate Current Year

            -12.13

            EPS Estimate Next Year

            -18.13

            EPS Estimate Current Quarter

            0.02

            EPS Estimate Next Quarter

            -0.22

            Most Recent Quarter

            -

            Profitability

            Revenue TTM

            6,996,000

            Gross Profit TTM

            -55,852,000

            EBITDA

            -94,375,000

            Profit Margin

            -143.04%

            Return On Assets TTM

            -22.73%

            Return On Equity TTM

            -1015.79%

            Revenue Per Share TTM

            1.74

            Qtly Revenue Growth YOY

            -89.20%

            Diluted Eps TTM

            -30

            Qtly Earnings Growth YOY

            53.60%

            Valuation

            Trailing PE

            0.00

            Forward PE

            61

            Price Sales TTM

            5.042

            Price Book MRQ

            53.8258

            Enterprise Value Revenue

            9

            Enterprise Value EBITDA

            0

            Peers analysis

            • CSL Ltd
              CSLLYCSL Ltd

              80.94

              0.99%
            • Regeneron Pharmaceuticals Inc
              REGNRegeneron Pharmaceuticals Inc

              564.37

              0.85%
            • UCB SA ADR
              UCBJYUCB SA ADR

              100.94

              0.65%
            • argenx SE
              ARGNFargenx SE

              547.60

              0.00%
            • UCB SA
              UCBJFUCB SA

              203.85

              0.00%
            • Vertex Pharmaceuticals Inc
              VRTXVertex Pharmaceuticals Inc

              470.35

              -1.95%
            • Alnylam Pharmaceuticals Inc
              ALNYAlnylam Pharmaceuticals Inc

              316.75

              -1.81%
            • Be
              ONCBeiGene, Ltd.

              249.50

              -1.60%
            • CSL Limited
              CMXHFCSL Limited

              152.18

              -0.14%
            • argenx NV ADR
              ARGXargenx NV ADR

              563.33

              -0.09%
            XM

            Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

            Trade with a Trusted, Award-Winning Broker.

            Trading involves risk. The value of investments may go up or down. Trade responsibly.

            FAQs

            What is FibroGen stock price today?

            What is FibroGen stock ticker?

            Is FGEN stock price going up?

            What is the analyst recommendation for FGEN?

            What is FGEN market cap?

            Does FGEN release financial reports?

            When is FGEN next earnings date?

            What were FGEN Earnings for the last quarter?

            What was FGEN Revenue for the last quarter?

            What was FGEN Net Income for the last quarter?

            Does FGEN pay dividends?

            How many employees does FGEN have?

            What is FGEN EBITDA?

            How to buy FGEN stocks?

            Should I invest in FGEN stock?